Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders

Stock Information for Coya Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Coya Therapeutics Inc.

Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference
Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results
Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer
Coya Therapeutics Announces Conference Call to Report Results from an Investigator-Initiated Phase 2 Trial of Low-Dose Interleukin-2 in Patients with Mild to Moderate Alzheimer's Disease
Coya Therapeutics Announces Closing of $10.0 Million Private Placement
Coya Therapeutics Announces $10.0 Million Private Placement
Coya Therapeutics Chairman and CEO Howard Berman Selected for PharmaVoice 100
Coya Therapeutics to Participate in Fireside Chat at the Chardan 8th Annual Genetic Medicines Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.